Table 2:

Distribution of persistence and clearance of high-risk human papillomavirus (HPV) infections in 67 women living with HIV who were high-risk HPV positive at baseline attended one-year follow-up

	Any high-risk HPV diagnosis at baseline n=67	HPV 16 infection* at baseline n=13	HPV 18 infection* at baseline n=14	Other high-risk HPV type infection* at baseline n=49
Persistence† of high-risk HPV infection
Treated with LEEP at baseline, n (%)	15 (22)	0 (0)	0 (0)	14 (29)
Not treated with LEEP at baseline, n (%)	16 (24)	3a (23)	2 (14)	12 (24)
Clearance‡ of high-risk HPV infection
Treated with LEEP at baseline, n (%)	30 (45)	6 (46)	8b (57)	20 (41)
Not treated with LEEP at baseline, n (%)	6 (9)	4 (31)	4c (29)	3 (6)

Abbreviations: LEEP: loop electrosurgical excision procedure

^*At baseline, 6 women were co-infected with HPV 16 and other hrHPV, 3 women were co-infected with HPV 18 and other hrHPV.

^†Persistence is defined as positivity of the same hrHPV type at baseline and at one-year follow-up.

^‡Clearance is defined as having a negative result for the same hrHPV type at one-year after a positive baseline hrHPV result.

^aOne participant was positive for both HPV16 and other high-risk HPV at baseline had persistent HPV 16 only

^bIncludes 1 participant with type switch from HPV18 at baseline to other high-risk HPV at follow-up

^cIncludes 1 participant with type switch from HPV18 at baseline to other high-risk HPV at follow-up